Literature DB >> 22907577

[Radiation biology of normal tissues. Scientific progress and perspectives].

W Dörr1, C Herskind.   

Abstract

Mesh：

Year:  2012        PMID： 22907577     DOI： 10.1007/s00066-012-0202-4

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  17 in total

1.  SNAI2 as a novel radioprotector of normal tissue by gene transfer using a lentiviral bicistronic SIN vector.

Authors:  Patrick Maier; Carsten Herskind; David Barzan; W Jens Zeller; Frederik Wenz
Journal:  Radiat Res       Date:  2010-05       Impact factor: 2.841

2.  Effects of systemic or topical administration of sodium selenite on early radiation effects in mouse oral mucosa.

Authors:  Anja Gehrisch; Wolfgang Dörr
Journal:  Strahlenther Onkol       Date:  2007-01       Impact factor: 3.621

3.  Three A's of repopulation during fractionated irradiation of squamous epithelia: Asymmetry loss, Acceleration of stem-cell divisions and Abortive divisions.

Authors:  W Dörr
Journal:  Int J Radiat Biol       Date:  1997-12       Impact factor: 2.694

4.  Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial.

Authors:  Michael Henke; Marc Alfonsi; Paolo Foa; Jordi Giralt; Etienne Bardet; Laura Cerezo; Michaela Salzwimmer; Richard Lizambri; Lara Emmerson; Mon-Gy Chen; Dietmar Berger
Journal:  J Clin Oncol       Date:  2011-06-13       Impact factor: 44.544

5.  Amelioration of early radiation effects in oral mucosa (mouse) by intravenous or subcutaneous administration of amifostine.

Authors:  Gabriele Fleischer; Wolfgang Dörr
Journal:  Strahlenther Onkol       Date:  2006-10       Impact factor: 3.621

Review 6.  Radioprotective gene therapy.

Authors:  Patrick Maier; Marlon R Veldwijk; Frederik Wenz
Journal:  Expert Opin Biol Ther       Date:  2011-05-02       Impact factor: 4.388

7.  Effect of selective inhibitors of inflammation on oral mucositis: preclinical studies.

Authors:  Julia Haagen; Hanna Krohn; Sophie Röllig; Margret Schmidt; Kathrin Wolfram; Wolfgang Dörr
Journal:  Radiother Oncol       Date:  2009-07-01       Impact factor: 6.280

8.  Effect of a prostaglandin--given rectally for prevention of radiation-induced acute proctitis--on late rectal toxicity. Results of a phase III randomized, placebo-controlled, double-blind study.

Authors:  Tereza Kertesz; Markus K A Herrmann; Antonia Zapf; Hans Christiansen; Robert M Hermann; Olivier Pradier; Heinz Schmidberger; Clemens F Hess; Andrea Hille
Journal:  Strahlenther Onkol       Date:  2009-09-12       Impact factor: 3.621

9.  Normal-tissue radioprotection by overexpression of the copper-zinc and manganese superoxide dismutase genes.

Authors:  Marlon R Veldwijk; Carsten Herskind; Leopold Sellner; Aleksandar Radujkovic; Stephanie Laufs; Stefan Fruehauf; W Jens Zeller; Frederik Wenz
Journal:  Strahlenther Onkol       Date:  2009-08-04       Impact factor: 3.621

10.  Effect of recombinant human keratinocyte growth factor (rHuKGF, Palifermin) on radiation-induced mouse urinary bladder dysfunction.

Authors:  Jana Jaal; Wolfgang Dörr
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-10-01       Impact factor: 7.038
View more
  2 in total

1.  Effects of bone marrow or mesenchymal stem cell transplantation on oral mucositis (mouse) induced by fractionated irradiation.

Authors:  M Schmidt; J Haagen; R Noack; A Siegemund; P Gabriel; W Dörr
Journal:  Strahlenther Onkol       Date:  2014-01-24       Impact factor: 3.621

2.  Dose-dependent uptake of 3'-deoxy-3'-[(18) F]fluorothymidine by the bowel after total-body irradiation.

Authors:  Markus Hartenbach; Andreas Delker; Sabrina Hartenbach; Juli Schlichtiger; Sabrina Niedermoser; Carmen Wängler; Björn Wängler; Guido Böning; Franz Josef Gildehaus; Klement Neumaier; Kirsten Lauber; Klaus Kraft; Claus Belka; Marcus Hacker; Viktor Meineke; Peter Bartenstein
Journal:  Mol Imaging Biol       Date:  2014-12       Impact factor: 3.488
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.